Low dose sufentanil for major intracranial surgery

Area of Science:

• Anesthesiology
• Neurosurgery
• Pharmacology

Background:

• Intracranial surgery requires precise anesthetic management.
• Balanced anesthesia techniques aim for cardiovascular stability and rapid recovery.
• Sufentanil is a potent opioid analgesic used in anesthesia.

Purpose of the Study:

• To evaluate the efficacy of single intravenous doses of sufentanil (3-5 µg/kg) in major intracranial surgery.
• To assess the impact of sufentanil dosage on intraoperative stability and postoperative recovery.
• To determine if the anesthetic technique influences recovery time in specific neurosurgical procedures.

Main Methods:

• A prospective study involving 41 patients undergoing major intracranial surgery.
• Administration of intravenous sufentanil in single doses ranging from 3 to 5 µg/kg.
• Utilizing a balanced anesthesia technique allowing for controlled cardiovascular parameters.
• Assessing postoperative recovery and neurological function.

Main Results:

• The 4 µg/kg dose of sufentanil demonstrated superior peroperative hemodynamic stability.
• Patients receiving the 4 µg/kg dose exhibited improved postoperative recovery.
• Delayed recovery observed in aneurysm and posterior fossa surgeries was not attributed to the anesthetic technique.

Conclusions:

• A single intravenous dose of 4 µg/kg sufentanil is optimal for major intracranial surgery.
• The chosen balanced anesthesia technique supports stable intraoperative conditions and facilitates rapid neurological assessment.
• Factors other than the anesthetic approach contribute to prolonged recovery in specific complex neurosurgical cases.